These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2199292)

  • 1. Bismuth therapy in gastrointestinal diseases.
    Gorbach SL
    Gastroenterology; 1990 Sep; 99(3):863-75. PubMed ID: 2199292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bismuth revisited in Helicobacter pylori gastro-duodenal infection].
    Caron F; Rouveix B
    Therapie; 1991; 46(5):393-8. PubMed ID: 1754987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.
    Brum JM; Gibb RD; Ramsey DL; Balan G; Yacyshyn BR
    Dig Dis Sci; 2021 Jul; 66(7):2323-2335. PubMed ID: 32772204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
    Du Pont HL
    Am J Med; 1985 Jun; 78(6B):81-90. PubMed ID: 3893119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively.
    Topfmeier P; Eberhardt R; Mateblowski M; Kuhn D
    Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):437-40. PubMed ID: 1800390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
    DuPont HL
    Drug Intell Clin Pharm; 1987 Sep; 21(9):687-93. PubMed ID: 3308391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
    Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
    Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bismuth therapy in gastroenterology].
    Raedsch R
    Dtsch Med Wochenschr; 1991 May; 116(21):821-4. PubMed ID: 2032534
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).
    DuPont HL; Sullivan P; Evans DG; Pickering LK; Evans DJ; Vollet JJ; Ericsson CD; Ackerman PB; Tjoa WS
    JAMA; 1980 Jan; 243(3):237-41. PubMed ID: 6985681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the treatment of Helicobacter pylori in the pediatric population.
    Robinson DM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Oct; 31(10):1247-9. PubMed ID: 9337451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.